Diagnosis of Metastatic Tumors on 68Ga-FAPI-RGD PET-CT and Radioligand Therapy

Description:

FAP and RGD are overexpressed in many tumor tissues. This study is intended to conduct preliminary clinical transformation and internal irradiation dosimetry research on 177Lu-FAPI-RGD--a new dual-targeted 177Lu therapeutic drug for the first time in the world.

Contacts:

Zhaohui Zhu, MD

13611093752@163.com

13611093752

177Lu-FAPI-RGD

Isotope(s):
Target(s):
  • αvβ3
  • FAP
Ligand: Peptides

68Ga-FAPI-RGD

Isotope(s):
Target(s):
  • αvβ3
  • FAP
Ligand: Peptides
XCancer

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468